Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$8,611,875
in 1 filing

Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. DeLuca Richard R. −$8.6M EVP&Pres, Merck Animal Heallth sold 34% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-04 Klobuchar Michael A EVP - Chief Strategy Officer Option exercise +885 $87.10 $77K 15,774.93
2022-05-04 Klobuchar Michael A EVP - Chief Strategy Officer Shares withheld for taxes −436 $87.10 $38K 15,338.93
2022-05-04 Klobuchar Michael A EVP - Chief Strategy Officer Option exercise · Restricted Stock Unit −885 1,772
2022-05-04 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Option exercise +813 $87.10 $71K 3,942.78
2022-05-04 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Shares withheld for taxes −279 $87.10 $24K 3,663.78
2022-05-04 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Option exercise · Restricted Stock Unit −813 1,629
2022-05-03 Oosthuizen Johannes Jacobus SVP, U.S. Market Grant or award · Stock Option (Right to Buy) +21,359 21,359
2022-05-03 Garay Arpa SVP Human Health Global Mktg. Grant or award · Stock Option (Right to Buy) +21,359 21,359
2022-05-03 Williams David Michael EVP,Chief Info&Digital Officer Grant or award · Stock Option (Right to Buy) +21,359 21,359
2022-05-03 Karachun Rita A Sr. VP Fince-Global Controller Grant or award · Stock Option (Right to Buy) +13,592 13,592
2022-05-03 Karachun Rita A Sr. VP Fince-Global Controller Grant or award · Restricted Stock Unit +2,411 2,411
2022-05-03 Zachary Jennifer EVP, General Counsel Grant or award · Stock Option (Right to Buy) +58,252 58,252
2022-05-03 MIZELL STEVEN EVP, Chief HR Officer Grant or award · Stock Option (Right to Buy) +40,777 40,777
2022-05-03 Li Dean Y Executive VP & President, MRL Grant or award · Stock Option (Right to Buy) +75,728 75,728
2022-05-03 Litchfield Caroline EVP & CFO Grant or award · Stock Option (Right to Buy) +53,398 53,398
2022-05-03 Klobuchar Michael A EVP - Chief Strategy Officer Grant or award · Stock Option (Right to Buy) +25,243 25,243
2022-05-03 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Grant or award · Stock Option (Right to Buy) +11,650 11,650
2022-05-03 LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer Grant or award · Restricted Stock Unit +2,067 2,067
2022-05-03 DeLuca Richard R. EVP&Pres, Merck Animal Heallth Grant or award · Stock Option (Right to Buy) +58,252 58,252
2022-05-03 Downing Cristal N Chief Comm. & Public Afrs Ofcr Grant or award · Stock Option (Right to Buy) +19,417 19,417

Page 35 of 42 · 823 trades